Key result
Higher serum fibrinogen levels were associated with more severe acute coronary syndromes and greater left ventricular dysfunction (444 mg/dl in severe vs 330 mg/dl in mild dysfunction).
Why the study?
ACS is the primary cause of mortality worldwide, and the study aimed to evaluate how fibrinogen and D-dimer levels associate with angiographic lesion severity and in-hospital and 30-day complications.
Are serum fibrinogen and plasma D-dimer levels associated with angiographic severity and complications in patients with acute coronary syndromes?
Observational (n=107)
Are serum fibrinogen and plasma D-dimer levels associated with angiographic severity and complications in patients with acute coronary syndromes?
Higher serum fibrinogen levels are associated with greater left ventricular dysfunction and more severe acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Fibrinogen and D-dimer levels may aid ACS risk stratification; leaves open whether they improve outcomes beyond current markers.
Background: Acute coronary syndromes (ACSs) are the primary cause of mortality worldwide. The aim of the study was to assess the as‑sociations of serum fibrinogen and plasma D‑dimer levels with angiographic severity of atherosclerotic lesions as well as the presence of in‑hospital complications and complications at 30‑day follow‑up in patients with ACS. Methods: This was a prospective study including 107 patients with ACS. Severity of CAD was assessed by the Gensini score. Correlations of D‑dimer and fibrinogen levels with complica‑tions such as heart failure, arrhythmia, recurrent angina, and cardiac death were assessed using the Pearson correlation coefficient and the receiver operating characteristic curve analysis. Results: The mean age of patients was 61±10.9 years. Mean serum fibrinogen levels were higher in individuals with severe left ventricular (LV) dysfunction than in those with moderate and mild LV dysfunction (444 mg/dl, 404 mg/dl, and 330 mg/dl, respectively). Similarly, the mean plasma D‑dimer level was higher in individuals with severe ACS (1.03 μg/ml) than in those with moderate (1.88 μg/ml) and mild ACS (3.5 μg/ml). Conclusion: Our study revealed that patients with higher serum fibrinogen levels tend to have more severe ACS, greater LV dysfunction, and a higher rate of complications. Therapies aimed at reducing fibrinogen levels might help reduce mortality and morbidity in patients with ACS.
No takes yet. Share an insight, caveat, or question.
Prabhu et al. (2020) conducted an observational in Acute coronary syndromes (n=107). Serum fibrinogen and plasma D-dimer levels vs. Lower levels was evaluated on Angiographic severity of atherosclerotic lesions and presence of in-hospital and 30-day complications. Higher serum fibrinogen levels were associated with more severe acute coronary syndromes and greater left ventricular dysfunction (444 mg/dl in severe vs 330 mg/dl in mild dysfunction).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: